Miocamycin
Product Specifications
UNSPSC Description
Miocamycin (Midecamycin acetate) is a derivative of midecamycin (HY-B1908), a macrolide antibiotic that can be isolated from a culture broth of Streptomyces mycarofaciens. Miocamycin has antibacterial properties[1].
Target Antigen
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/miocamycin.html
Solubility
10 mM in DMSO
Smiles
CO[C@@H]([C@@H](CC(O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]1CC=O)C)OC(C)=O)C)=O)OC(CC)=O)[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)OC(CC)=O)OC(C)=O)N(C)C)O
Molecular Weight
898.04
References & Citations
[1]TOXICOLOGICAL STUDIES ON A NEW MACROLIDE ANTIBIOTIC, MIDECAMYCIN ACETATE (MIOCAMYCIN). July 1984. Volume 37 Issue 7 Pages 1355-1375.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B1921/Miocamycin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B1921/
Clinical Information
No Development Reported
CAS Number
55881-07-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal XTP12 Antibody [DyLight 405]](https://cdn.genprice.uk/genprice/genprice2.png)
